Senior Vice President#BR# Global Development
Anette Oestergaard joined Ferring Pharmaceuticals in July 2018. She is responsible for all global clinical development activities in Ferring Pharmaceuticals and is a member of the R&D management team. Anette has 25 years of experience in Drug Development from various leadership positions at MC2 Therapeutics, Leo Pharma A/S, Genmab A/S and Pharmexa A/S.
Anette holds a MSc in Pharmacy from Copenhagen University, a Diploma in Pharmaceutical Medicine from the European Centre of Pharmaceutical Medicine in Basel and an Executive MBA from Middlesex University.